IGF1 and metabolic syndrome: Although relatively little is known about the exact carcinogenic mechanisms of metabolic syndrome, changes in the expression of transcription and growth factors in the peripheral tissues, as well as in cancer tissues of patients with metabolic syndrome, and changes of bioavailable concentrations of insulin-like growth factor-1 conferred by the influence of hyperinsulinemia, might constitute possible mechanisms (26, 27).